CDK2 and hepatocellular carcinoma: We then classified the CCNE1 and CDK2 expression in these patients according to demographic, pathological and molecular characteristics of three well-described, different HCC subtypes (integrated clusters iClust1, 2, 3) identified by integrative in silico multi-platform subtyping approaches [40] (see Supplementary Table S2 and [41]).